REUTERS / Alamy Stock Photo
Risky life-science projects need global governance. Unfortunately, current standards and practices are not up to the task.
CORBEVAX uses recombinant DNA technology that many countries already have the infrastructure to produce.
Artis777 via iStock/Getty Images Plus
CORBEVAX is anticipated to significantly expand vaccine access to people in low- and middle-income countries.
White raccoon dogs are prized for their unusual fur.
In China, the wildlife trade is thriving, driven by the increased demands for luxury goods and traditional medicine. But there is real concern about the threat of diseases that can cross over to humans.
In reprioritizing public health, the U.S. limited its ability to respond quickly and effectively to the pandemic.
Anton Petrus/Moment via Getty Images
While neoliberalism has allowed U.S. markets to grow, the resultant stunted public health system left Americans to figure out how to protect themselves from COVID-19 and its fallout on their own.
In east Asian countries, past disease outbreaks have made face masks part of everyday life – but the social context supporting such behaviour isn’t present in the UK.
Bianca De Marchi/AAP
In Hong Kong, SARS created a new social norm, where people accepted mask use as part of their ‘civic responsibility’.
The prevention of future pandemics requires examining viral family trees.
Stockcrafter/iStock via Getty Images Plus
Bat hosts, lab leaks – tracing SARS-CoV-2 to its origins involves more than just tracking down patient zero.
A sign in County Kildare, Ireland. in March 2020. Epidemiologists around the world worked hard to try to stop big parties in the face of rising caseloads of what would come to be called COVID-19.
Niall Carson/PA Images via Getty Images
The US was not ready for the coronavirus pandemic in 2020. What can public health leaders and policymakers do to make sure we don’t face another winter of rampant disease?
The Fairmont Royal York Hotel in Toronto. After the SARS pandemic in 2003, Toronto hotels faced a recovery period.
After SARS in 2003, an effort was made by Toronto’s tourism and hospitality industries to stimulate the sector’s recovery. But measures weren’t put in place for future pandemics.
The COVID-19 new normal might be here for quite some time.
SolStock/E+ via Getty Images
As ready as you are to be done with COVID-19, it’s not going anywhere soon. A historian of disease describes how once a pathogen emerges, it’s usually here to stay.
Is COVID-19 hitting men harder than women?
UpperCut Images/Getty Images
A new study is the first to identify sex differences in inflammation and immune cell activation in response to SARS-CoV-2 infection, which causes COVID-19.
A worker inspects vials of a SARS CoV-2 vaccine for COVID-19 produced by SinoVac at its factory in Beijing on Sept. 24, 2020.
(AP Photo/Ng Han Guan)
Our first exposure to a pathogen, either naturally or via vaccination, can affect how our immune system responds in the future to the same or similar pathogens.
The polymerase chain reaction, or PCR, is used to copy strands of DNA.
COVID-19 tests rely on a process developed at a biotech company co-founded by a Canadian. Canada’s current testing expertise needs to be channelled to prepare for the next wave, and the next pandemic.
Dan Peled/AAP Image
Australia’s island identity and attitude to border security was forged from handling pandemics since the time of federation. Here’s what we’ve learned along the way.
We are slowly figuring out which drugs and therapies are effective against the new coronavirus.
Anton Petrus / Getty Images
During the last six months, news reports have mentioned dozens of drugs that may be effective against the new coronavirus. Here we lay out the evidence and reveal which ones are proven to work. Or not.
A security guard checks the body temperature of a motorcyclist as a preventive measure.
Risa Krisadhi/SOPA Images/LightRocket via Getty Images
Detecting fever requires measuring core body temperature. Screening measures the body’s surface temperature.
A few people in the crowd will be responsible for the bulk of a disease’s spread.
Pacific Press /LightRocket via Getty Images
Epidemiological data suggests that 80% of COVID-19 cases can be traced to just 20% of those infected with SARS-CoV-2.
The virus that caused the original Sars no longer haunts us, but the characteristics of today’s coronavirus mean it’s unlikely to disappear in the same way.
Moderna just released the results of a phase 1 trial for a COVID-19 vaccine.
JOSEPH PREZIOSO/AFP via Getty Images
Results from phase 1 trials of a COVID-19 mRNA vaccine created a burst of optimism. But details the company failed to release suggest it is too early to speculate whether the vaccine is effective.
A bottle of Covid Organics, a herbal tea that authorities in Madagascar gave to students.
Photo by Rijasolo/AFP via Getty Images
Authorities around the world can do more to ensure that correct information and messages on the pandemic reach everybody.